[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Islet Amyloid Polypeptide Market Report 2017

December 2017 | 100 pages | ID: UBC01EF68C4EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Islet Amyloid Polypeptide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Islet Amyloid Polypeptide in these regions, from 2012 to 2022 (forecast).
United States Islet Amyloid Polypeptide market competition by top manufacturers/players, with Islet Amyloid Polypeptide sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Adocia SAS
  • AstraZeneca Plc
  • Eli Lilly and Co
  • Neurimmune Holding AG
  • Nordic Bioscience A/S
  • Prothena Corp Plc
  • reMYND NV
  • Zealand Pharma AS
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • AC-253
  • DACRA-042
  • DACRA-089
  • KBP-056
  • KBP-088
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Metabolic Disorders
  • Gastrointestinal
  • Musculoskeletal Disorders
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Islet Amyloid Polypeptide Market Report 2017

1 ISLET AMYLOID POLYPEPTIDE OVERVIEW

1.1 Product Overview and Scope of Islet Amyloid Polypeptide
1.2 Classification of Islet Amyloid Polypeptide by Product Category
  1.2.1 United States Islet Amyloid Polypeptide Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Islet Amyloid Polypeptide Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 AC-253
  1.2.4 DACRA-042
  1.2.5 DACRA-089
  1.2.6 KBP-056
  1.2.7 KBP-088
  1.2.8 Others
1.3 United States Islet Amyloid Polypeptide Market by Application/End Users
  1.3.1 United States Islet Amyloid Polypeptide Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Metabolic Disorders
  1.3.3 Gastrointestinal
  1.3.4 Musculoskeletal Disorders
  1.3.5 Others
1.4 United States Islet Amyloid Polypeptide Market by Region
  1.4.1 United States Islet Amyloid Polypeptide Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Islet Amyloid Polypeptide Status and Prospect (2012-2022)
  1.4.3 Southwest Islet Amyloid Polypeptide Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Islet Amyloid Polypeptide Status and Prospect (2012-2022)
  1.4.5 New England Islet Amyloid Polypeptide Status and Prospect (2012-2022)
  1.4.6 The South Islet Amyloid Polypeptide Status and Prospect (2012-2022)
  1.4.7 The Midwest Islet Amyloid Polypeptide Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Islet Amyloid Polypeptide (2012-2022)
  1.5.1 United States Islet Amyloid Polypeptide Sales and Growth Rate (2012-2022)
  1.5.2 United States Islet Amyloid Polypeptide Revenue and Growth Rate (2012-2022)

2 UNITED STATES ISLET AMYLOID POLYPEPTIDE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Islet Amyloid Polypeptide Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Islet Amyloid Polypeptide Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Islet Amyloid Polypeptide Average Price by Players/Suppliers (2012-2017)
2.4 United States Islet Amyloid Polypeptide Market Competitive Situation and Trends
  2.4.1 United States Islet Amyloid Polypeptide Market Concentration Rate
  2.4.2 United States Islet Amyloid Polypeptide Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Islet Amyloid Polypeptide Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ISLET AMYLOID POLYPEPTIDE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Islet Amyloid Polypeptide Sales and Market Share by Region (2012-2017)
3.2 United States Islet Amyloid Polypeptide Revenue and Market Share by Region (2012-2017)
3.3 United States Islet Amyloid Polypeptide Price by Region (2012-2017)

4 UNITED STATES ISLET AMYLOID POLYPEPTIDE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Islet Amyloid Polypeptide Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Islet Amyloid Polypeptide Revenue and Market Share by Type (2012-2017)
4.3 United States Islet Amyloid Polypeptide Price by Type (2012-2017)
4.4 United States Islet Amyloid Polypeptide Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ISLET AMYLOID POLYPEPTIDE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Islet Amyloid Polypeptide Sales and Market Share by Application (2012-2017)
5.2 United States Islet Amyloid Polypeptide Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ISLET AMYLOID POLYPEPTIDE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Adocia SAS
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Islet Amyloid Polypeptide Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Adocia SAS Islet Amyloid Polypeptide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca Plc
  6.2.2 Islet Amyloid Polypeptide Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Plc Islet Amyloid Polypeptide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly and Co
  6.3.2 Islet Amyloid Polypeptide Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lilly and Co Islet Amyloid Polypeptide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Neurimmune Holding AG
  6.4.2 Islet Amyloid Polypeptide Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Neurimmune Holding AG Islet Amyloid Polypeptide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Nordic Bioscience A/S
  6.5.2 Islet Amyloid Polypeptide Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Nordic Bioscience A/S Islet Amyloid Polypeptide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Prothena Corp Plc
  6.6.2 Islet Amyloid Polypeptide Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Prothena Corp Plc Islet Amyloid Polypeptide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 reMYND NV
  6.7.2 Islet Amyloid Polypeptide Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 reMYND NV Islet Amyloid Polypeptide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Zealand Pharma AS
  6.8.2 Islet Amyloid Polypeptide Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Zealand Pharma AS Islet Amyloid Polypeptide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 ISLET AMYLOID POLYPEPTIDE MANUFACTURING COST ANALYSIS

7.1 Islet Amyloid Polypeptide Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Islet Amyloid Polypeptide

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Islet Amyloid Polypeptide Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Islet Amyloid Polypeptide Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ISLET AMYLOID POLYPEPTIDE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Islet Amyloid Polypeptide Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Islet Amyloid Polypeptide Sales Volume Forecast by Type (2017-2022)
11.3 United States Islet Amyloid Polypeptide Sales Volume Forecast by Application (2017-2022)
11.4 United States Islet Amyloid Polypeptide Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Islet Amyloid Polypeptide
Figure United States Islet Amyloid Polypeptide Market Size (K Pcs) by Type (2012-2022)
Figure United States Islet Amyloid Polypeptide Sales Volume Market Share by Type (Product Category) in 2016
Figure AC-253 Product Picture
Figure DACRA-042 Product Picture
Figure DACRA-089 Product Picture
Figure KBP-056 Product Picture
Figure KBP-088 Product Picture
Figure Others Product Picture
Figure United States Islet Amyloid Polypeptide Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Islet Amyloid Polypeptide by Application in 2016
Figure Metabolic Disorders Examples
Table Key Downstream Customer in Metabolic Disorders
Figure Gastrointestinal Examples
Table Key Downstream Customer in Gastrointestinal
Figure Musculoskeletal Disorders Examples
Table Key Downstream Customer in Musculoskeletal Disorders
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Islet Amyloid Polypeptide Market Size (Million USD) by Region (2012-2022)
Figure The West Islet Amyloid Polypeptide Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Islet Amyloid Polypeptide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Islet Amyloid Polypeptide Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Islet Amyloid Polypeptide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Islet Amyloid Polypeptide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Islet Amyloid Polypeptide Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Islet Amyloid Polypeptide Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Islet Amyloid Polypeptide Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Islet Amyloid Polypeptide Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Islet Amyloid Polypeptide Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Islet Amyloid Polypeptide Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Islet Amyloid Polypeptide Sales Share by Players/Suppliers
Figure 2017 United States Islet Amyloid Polypeptide Sales Share by Players/Suppliers
Figure United States Islet Amyloid Polypeptide Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Islet Amyloid Polypeptide Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Islet Amyloid Polypeptide Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Islet Amyloid Polypeptide Revenue Share by Players/Suppliers
Figure 2017 United States Islet Amyloid Polypeptide Revenue Share by Players/Suppliers
Table United States Market Islet Amyloid Polypeptide Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Islet Amyloid Polypeptide Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Islet Amyloid Polypeptide Market Share of Top 3 Players/Suppliers
Figure United States Islet Amyloid Polypeptide Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Islet Amyloid Polypeptide Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Islet Amyloid Polypeptide Product Category
Table United States Islet Amyloid Polypeptide Sales (K Pcs) by Region (2012-2017)
Table United States Islet Amyloid Polypeptide Sales Share by Region (2012-2017)
Figure United States Islet Amyloid Polypeptide Sales Share by Region (2012-2017)
Figure United States Islet Amyloid Polypeptide Sales Market Share by Region in 2016
Table United States Islet Amyloid Polypeptide Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Islet Amyloid Polypeptide Revenue Share by Region (2012-2017)
Figure United States Islet Amyloid Polypeptide Revenue Market Share by Region (2012-2017)
Figure United States Islet Amyloid Polypeptide Revenue Market Share by Region in 2016
Table United States Islet Amyloid Polypeptide Price (USD/Pcs) by Region (2012-2017)
Table United States Islet Amyloid Polypeptide Sales (K Pcs) by Type (2012-2017)
Table United States Islet Amyloid Polypeptide Sales Share by Type (2012-2017)
Figure United States Islet Amyloid Polypeptide Sales Share by Type (2012-2017)
Figure United States Islet Amyloid Polypeptide Sales Market Share by Type in 2016
Table United States Islet Amyloid Polypeptide Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Islet Amyloid Polypeptide Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Islet Amyloid Polypeptide by Type (2012-2017)
Figure Revenue Market Share of Islet Amyloid Polypeptide by Type in 2016
Table United States Islet Amyloid Polypeptide Price (USD/Pcs) by Types (2012-2017)
Figure United States Islet Amyloid Polypeptide Sales Growth Rate by Type (2012-2017)
Table United States Islet Amyloid Polypeptide Sales (K Pcs) by Application (2012-2017)
Table United States Islet Amyloid Polypeptide Sales Market Share by Application (2012-2017)
Figure United States Islet Amyloid Polypeptide Sales Market Share by Application (2012-2017)
Figure United States Islet Amyloid Polypeptide Sales Market Share by Application in 2016
Table United States Islet Amyloid Polypeptide Sales Growth Rate by Application (2012-2017)
Figure United States Islet Amyloid Polypeptide Sales Growth Rate by Application (2012-2017)
Table Adocia SAS Basic Information List
Table Adocia SAS Islet Amyloid Polypeptide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Adocia SAS Islet Amyloid Polypeptide Sales Growth Rate (2012-2017)
Figure Adocia SAS Islet Amyloid Polypeptide Sales Market Share in United States (2012-2017)
Figure Adocia SAS Islet Amyloid Polypeptide Revenue Market Share in United States (2012-2017)
Table AstraZeneca Plc Basic Information List
Table AstraZeneca Plc Islet Amyloid Polypeptide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Plc Islet Amyloid Polypeptide Sales Growth Rate (2012-2017)
Figure AstraZeneca Plc Islet Amyloid Polypeptide Sales Market Share in United States (2012-2017)
Figure AstraZeneca Plc Islet Amyloid Polypeptide Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Co Basic Information List
Table Eli Lilly and Co Islet Amyloid Polypeptide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly and Co Islet Amyloid Polypeptide Sales Growth Rate (2012-2017)
Figure Eli Lilly and Co Islet Amyloid Polypeptide Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Co Islet Amyloid Polypeptide Revenue Market Share in United States (2012-2017)
Table Neurimmune Holding AG Basic Information List
Table Neurimmune Holding AG Islet Amyloid Polypeptide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Neurimmune Holding AG Islet Amyloid Polypeptide Sales Growth Rate (2012-2017)
Figure Neurimmune Holding AG Islet Amyloid Polypeptide Sales Market Share in United States (2012-2017)
Figure Neurimmune Holding AG Islet Amyloid Polypeptide Revenue Market Share in United States (2012-2017)
Table Nordic Bioscience A/S Basic Information List
Table Nordic Bioscience A/S Islet Amyloid Polypeptide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Nordic Bioscience A/S Islet Amyloid Polypeptide Sales Growth Rate (2012-2017)
Figure Nordic Bioscience A/S Islet Amyloid Polypeptide Sales Market Share in United States (2012-2017)
Figure Nordic Bioscience A/S Islet Amyloid Polypeptide Revenue Market Share in United States (2012-2017)
Table Prothena Corp Plc Basic Information List
Table Prothena Corp Plc Islet Amyloid Polypeptide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Prothena Corp Plc Islet Amyloid Polypeptide Sales Growth Rate (2012-2017)
Figure Prothena Corp Plc Islet Amyloid Polypeptide Sales Market Share in United States (2012-2017)
Figure Prothena Corp Plc Islet Amyloid Polypeptide Revenue Market Share in United States (2012-2017)
Table reMYND NV Basic Information List
Table reMYND NV Islet Amyloid Polypeptide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure reMYND NV Islet Amyloid Polypeptide Sales Growth Rate (2012-2017)
Figure reMYND NV Islet Amyloid Polypeptide Sales Market Share in United States (2012-2017)
Figure reMYND NV Islet Amyloid Polypeptide Revenue Market Share in United States (2012-2017)
Table Zealand Pharma AS Basic Information List
Table Zealand Pharma AS Islet Amyloid Polypeptide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Zealand Pharma AS Islet Amyloid Polypeptide Sales Growth Rate (2012-2017)
Figure Zealand Pharma AS Islet Amyloid Polypeptide Sales Market Share in United States (2012-2017)
Figure Zealand Pharma AS Islet Amyloid Polypeptide Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Islet Amyloid Polypeptide
Figure Manufacturing Process Analysis of Islet Amyloid Polypeptide
Figure Islet Amyloid Polypeptide Industrial Chain Analysis
Table Raw Materials Sources of Islet Amyloid Polypeptide Major Players/Suppliers in 2016
Table Major Buyers of Islet Amyloid Polypeptide
Table Distributors/Traders List
Figure United States Islet Amyloid Polypeptide Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Islet Amyloid Polypeptide Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Islet Amyloid Polypeptide Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Islet Amyloid Polypeptide Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Islet Amyloid Polypeptide Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Islet Amyloid Polypeptide Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Islet Amyloid Polypeptide Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Islet Amyloid Polypeptide Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Islet Amyloid Polypeptide Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Islet Amyloid Polypeptide Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Islet Amyloid Polypeptide Sales Volume Share Forecast by Region (2017-2022)
Figure United States Islet Amyloid Polypeptide Sales Volume Share Forecast by Region (2017-2022)
Figure United States Islet Amyloid Polypeptide Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories